2/23
08:00 am
rna
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
Low
Report
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
2/18
05:00 pm
rna
The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
Low
Report
The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
2/2
10:08 pm
rna
Avidity Biosciences Announces Expected Record Date for Spin-Off [Yahoo! Finance]
Low
Report
Avidity Biosciences Announces Expected Record Date for Spin-Off [Yahoo! Finance]
2/2
09:44 pm
rna
Avidity Biosciences Announces Expected Record Date for Spin-Off
Low
Report
Avidity Biosciences Announces Expected Record Date for Spin-Off
1/23
05:06 am
rna
Avidity Biosciences (NASDAQ:RNA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Avidity Biosciences (NASDAQ:RNA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/13
12:02 pm
rna
JPM26: Novartis strengthens neuroscience portfolio with bolt-on deals [Yahoo! Finance]
Low
Report
JPM26: Novartis strengthens neuroscience portfolio with bolt-on deals [Yahoo! Finance]
1/13
06:33 am
rna
SciNeuro and Novartis sign global licensing deal for Alzheimer's antibody [Yahoo! Finance]
Low
Report
SciNeuro and Novartis sign global licensing deal for Alzheimer's antibody [Yahoo! Finance]
12/19
05:58 am
rna
Avidity Biosciences (NASDAQ:RNA) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
Low
Report
Avidity Biosciences (NASDAQ:RNA) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
12/18
11:03 am
rna
Avidity Biosciences (NASDAQ:RNA) was given a new $72.00 price target on by analysts at Evercore ISI.
Low
Report
Avidity Biosciences (NASDAQ:RNA) was given a new $72.00 price target on by analysts at Evercore ISI.
12/11
01:33 am
rna
Assessing Avidity Biosciences (RNA) Valuation After a 130% Year-to-Date Share Price Surge [Yahoo! Finance]
Low
Report
Assessing Avidity Biosciences (RNA) Valuation After a 130% Year-to-Date Share Price Surge [Yahoo! Finance]
12/10
01:47 pm
rna
Dyne upgraded at Oppenheimer on upcoming trial readout from Avidity [Seeking Alpha]
Low
Report
Dyne upgraded at Oppenheimer on upcoming trial readout from Avidity [Seeking Alpha]
12/4
02:02 pm
rna
Avidity Biosciences, Inc. (RNA): A Bull Case Theory [Yahoo! Finance]
Low
Report
Avidity Biosciences, Inc. (RNA): A Bull Case Theory [Yahoo! Finance]